Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians

Qaseem, Amir, Barry, Michael J., Humphrey, Linda L., Forciea, Mary Ann, for the Clinical Guidelines Committee of the American College of Physicians* · 2017 · Annals of Internal Medicine

Abstract

Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endorsed by the American Academy of Family Physicians. Methods: This guideline is based on a systematic review of randomized, controlled trials and observational studies published through December 2015 on the comparative effectiveness of oral medications for type 2 diabetes. Evaluated interventions included metformin, thiazolidinediones, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodium–glucose cotransporter-2 (SGLT-2) inhibitors. Study quality was assessed, data were extracted, and results were summarized qualitatively on the basis of the totality of evidence identified by using several databases. Evaluated outcomes included intermediate outcomes of hemoglobin A1c, weight, systolic blood pressure, and heart rate; all-cause mortality; cardiovascular and cerebrovascular morbidity and mortality; retinopathy, nephropathy, and neuropathy; and harms. This guideline grades the recommendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Target Audience and Patient Population: The target audience for this guideline includes all clinicians, and the target patient population includes adults with type 2 diabetes. Recommendation 1: ACP recommends that clinicians prescribe metformin to patients with type 2 diabetes when pharmacologic therapy is needed to improve glycemic control. (Grade: strong recommendation; moderate-quality evidence) Recommendation 2: ACP recommends that clinicians consider adding either a sulfonylurea, a thiazolidinedione, an SGLT-2 inhibitor, or a DPP-4 inhibitor to metformin to improve glycemic control when a second oral therapy is considered. (Grade: weak recommendation; moderate-quality evidence.) ACP recommends that clinicians and patients select among medications after discussing benefits, adverse effects, and costs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/m16-1860

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 121

  1. 10.7326/0003-4819-156-3-201202070-00011 · DOI · Paper page
  2. 10.1007/s00125-010-1906-6 · DOI
  3. 10.1093/eurheartj/ehr077 · DOI · Paper page
  4. 10.1007/s00125-013-2958-1 · DOI
  5. 10.1111/j.1463-1326.2012.01604.x · DOI
  6. 10.1007/s00228-010-0939-6 · DOI
  7. Wang CP, 2014, J Endocrinol Diabetes Obes, 2, 1031
  8. 10.1016/j.metabol.2009.03.007 · DOI
  9. 10.1016/j.diabres.2008.07.021 · DOI
  10. 10.1055/s-0034-1370989 · doi:10.1055/s-0034-1370989
  11. 10.1111/j.1463-1326.2011.01367.x · DOI
  12. 10.1055/s-0034-1396864 · DOI
  13. 10.1111/jdi.12157 · DOI
  14. 10.1007/s00592-011-0276-y · DOI
  15. 10.1007/s12325-013-0003-x · DOI
  16. 10.1111/j.1463-1326.2008.00965.x · DOI
  17. 10.2337/diabetes.51.12.3479 · DOI · Paper page
  18. Iliadis F, 2007, In Vivo, 21, 1107
  19. 10.1055/s-0029-1202792 · DOI
  20. 10.1016/j.diabres.2009.07.004 · DOI
  21. 10.2337/diacare.27.1.41 · DOI
  22. 10.1210/jc.2002-021786 · DOI · Paper page
  23. 10.1185/03007990903350011 · DOI
  24. Ramachandran A, 2004, J Assoc Physicians India, 52, 459
  25. 10.1111/j.1463-1326.2006.00659.x · DOI
  26. 10.2337/dc11-1107 · DOI · Paper page
  27. 10.1210/jc.2003-030861 · DOI · Paper page
  28. 10.1016/j.peptides.2012.12.020 · DOI
  29. 10.1111/j.1464-5491.2005.01656.x · DOI
  30. 10.4093/dmj.2011.35.1.26 · DOI
  31. 10.5551/jat.14.86 · DOI
  32. 10.1016/j.numecd.2005.12.003 · DOI
  33. 10.1592/phco.26.10.1388 · DOI
  34. 10.1016/j.metabol.2004.05.013 · DOI
  35. 10.1016/S1056-8727(00)00124-0 · DOI
  36. 10.1038/sj.jhh.1001444 · DOI · Paper page
  37. 10.1016/j.jacc.2005.03.041 · DOI · Paper page
  38. 10.1016/S0149-2918(04)90068-9 · DOI
  39. 10.1111/j.1464-5491.2004.01258.x · DOI
  40. 10.1002/dmrr.633 · DOI
  41. 10.1111/j.2040-1124.2011.00115.x · DOI
  42. 10.1185/03007990802705679 · DOI
  43. 10.1111/j.1463-1326.2009.01187.x · DOI
  44. 10.1111/j.1463-1326.2009.01056.x · DOI · Paper page
  45. 10.1111/dom.12258 · DOI
  46. 10.1111/j.1463-1326.2010.01204.x · DOI
  47. 10.1111/j.1463-1326.2012.01590.x · DOI
  48. 10.1111/j.1463-1326.2011.01385.x · DOI
  49. 10.1111/dom.12011 · DOI
  50. 10.1053/j.ajkd.2012.11.043 · DOI
  51. 10.1111/j.1463-1326.2007.00839.x · DOI · Paper page
  52. 10.1111/j.1742-1241.2012.02911.x · DOI · Paper page
  53. 10.2337/dc13-0663 · DOI · Paper page
  54. 10.1111/dom.12185 · DOI · Paper page
  55. 10.2337/dc11-1926 · DOI · Paper page
  56. 10.1007/s00125-013-3039-1 · DOI · Paper page
  57. 10.2337/dc14-1142 · DOI · Paper page
  58. 10.1111/dom.12459 · DOI · Paper page
  59. 10.1016/S0140-6736(13)60683-2 · DOI · Paper page
  60. 10.2337/dc11-0606 · DOI · Paper page
  61. 10.1016/S2213-8587(14)70120-2 · DOI · Paper page
  62. 10.2337/dc13-2762 · DOI · Paper page
  63. 10.4158/EP09146.OR · DOI
  64. 10.4103/0976-500X.107656 · DOI
  65. 10.1016/S0140-6736(10)60590-9 · DOI · Paper page
  66. 10.1210/jc.2011-2243 · DOI
  67. 10.1111/j.1464-5491.2007.02160.x · DOI
  68. 10.1097/01.hjh.0000244955.39491.88 · DOI
  69. 10.1185/030079906X104786 · DOI
  70. 10.1592/phco.25.5.637.63587 · DOI
  71. 10.1111/j.1463-1326.2005.00570.x · DOI
  72. 10.1097/MEG.0b013e3283608317 · DOI
  73. 10.1007/s00508-009-1279-3 · DOI
  74. 10.1055/s-2007-984441 · DOI
  75. 10.1016/S2213-8587(13)70084-6 · DOI · Paper page
  76. 10.2337/dc10-0159 · DOI
  77. 10.2337/diacare.25.11.2058 · DOI · Paper page
  78. 10.1185/03007990902820816 · DOI
  79. 10.1001/jama.283.13.1695 · DOI · Paper page
  80. 10.1016/j.diabres.2004.09.002 · DOI
  81. 10.1210/jc.2002-021225 · DOI
  82. 10.1016/S0149-2918(03)80112-1 · DOI
  83. 10.1046/j.1464-5491.2002.00774.x · DOI
  84. 10.1046/j.1463-1326.2002.00211.x · DOI
  85. 10.2337/diacare.17.10.1100 · DOI · Paper page
  86. Hermann LS, 1991, Diabete Metab, 17, 201
  87. 10.1046/j.1464-5491.2001.00582.x · DOI
  88. 10.1111/j.1464-5491.2010.03131.x · DOI
  89. 10.1007/s13300-012-0013-8 · DOI
  90. 10.1111/j.1463-1326.2011.01390.x · DOI
  91. 10.1016/j.diabres.2011.07.035 · DOI
  92. 10.1111/j.1753-0407.2012.00213.x · DOI
  93. 10.2169/internalmedicine.52.8175 · DOI
  94. 10.1186/1472-6823-14-17 · DOI
  95. 10.1185/03007995.2012.714360 · DOI
  96. 10.1111/j.1742-1241.2008.01933.x · DOI · Paper page
  97. 10.1111/j.1463-1326.2010.01326.x · DOI · Paper page
  98. 10.1111/j.1463-1326.2012.01620.x · DOI
  99. 10.1111/1753-0407.12284 · DOI
  100. Qiu R, 2014, J Clin Transl Endocrinol, 1, 54
  101. 10.2337/dc13-2105 · DOI · Paper page
  102. 10.1111/j.1463-1326.2010.01334.x · DOI · Paper page
  103. 10.1002/dmrr.2525 · DOI
  104. 10.1111/j.1463-1326.2006.00704.x · DOI · Paper page
  105. 10.1111/dom.12461 · DOI
  106. 10.1111/dom.12387 · DOI
  107. 10.1139/cjpp-2012-0300 · DOI
  108. 10.1111/j.1464-5491.2012.03589.x · DOI · Paper page
  109. 10.1046/j.1463-1326.2002.00229.x · DOI
  110. 10.1016/S1726-4901(08)70044-3 · DOI
  111. 10.1111/jdi.12201 · DOI
  112. 10.2337/dc14-0024 · DOI · Paper page
  113. Gupta A, 2013, Int J Pharm Sci Rev Res, 23, 137
  114. 10.1111/j.1742-1241.2010.02510.x · DOI · Paper page
  115. 10.1111/j.1742-1241.2010.02353.x · DOI · Paper page
  116. 10.1016/S0140-6736(12)60691-6 · DOI · Paper page
  117. 10.1111/dom.12377 · DOI
  118. 10.2165/11316510-000000000-00000 · DOI
  119. 10.1186/1741-7015-11-43 · DOI · Paper page
  120. 10.1111/dom.12189 · DOI · Paper page
  121. 10.1016/0197-2456(95)00134-4 · DOI · Paper page

Cited by

See all 207

Metadata

Authors
Qaseem, A., Barry, M. J., Humphrey, L. L., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians*
Venue
Annals of Internal Medicine
Published
2017-02-21
Volume
166
Issue
4
Pages
279-290
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W4233007762
Cited by
207
References
12
FWCI
22.27
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.